14 April, 2022

ARCU Capital Announces the Sale of Grupo Torre Medica

Mexico City, Mexico – February 1, 2022 – ARCU Capital (ARCU) is pleased to announce that it has successfully sold its interests in Grupo Torre Medica to Hydal, an industry leader in healthcare services.

Grupo Torre Medica is a leading healthcare services company that provides quality healthcare to low and middle income populations in Mexico through an innovative healthcare delivery model aimed at achieving profitability, quality of service and scale concurrently.  As one of Mexico City’s largest providers of inpatient and outpatient care, Grupo Torre Medica offers high-quality medicine across the full spectrum of care and treats more than 150 thousand patients annually.

“We are thrilled to be joining Hydal,” said Grupo Torre Medica CEO, Gustavo Fernandez de Loyola. “Our employees will be afforded enhanced career growth opportunities as part of Hydal, and our customers will enjoy broader service line offerings with a continued focus on accessible healthcare.”

Julian Arber, Managing Partner at ARCU, added, “We were proud to lead Grupo Torre Medica into a national market leader while creating such a valuable and customer service-oriented company.”

About ARCU Capital
ARCU Capital is a private equity firm focused on lower middle-market companies across a wide range of industries. Since its founding, ARCU Capital has invested in superior businesses in attractive industries, always as a lead investor. The firm focuses on investing in sound businesses with established operating histories, rather than startups and turnarounds. For more information on ARCU Capital, please visit